Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension - PubMed (original) (raw)
. 1990 Feb;252(2):526-30.
Affiliations
- PMID: 2313587
Phorbol-12,13-dibutyrate-induced vasoconstriction in vivo: characterization of response in genetic hypertension
G E Bilder et al. J Pharmacol Exp Ther. 1990 Feb.
Abstract
To assess the role of protein kinase C (PKC) in the control of vessel tone in vivo in genetic hypertension, the vascular effects of phorbol-12,13-dibutyrate (PDBu), a PKC activator, was measured in the autoperfused hindlimb of reserpinized spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY). PDBu infusion (1-3000 ng/kg/min) into the hindlimb elevated perfusion pressure in a dose-related manner. Vasoconstriction response characteristics (latency, T1/2 to peak effect, decay of effect) of PDBu were significantly longer (2- to 10-fold) than that produced by membrane receptor agonists; phenylephrine, SKF 89748, a lipophilic alpha-1 agonist, angiotensin II and 5-hydroxytryptamine. The tonic vasoconstriction induced by PDBu was not antagonized by prazosin, rauwolscine, cyproheptadine, [Sar1lle8]-angiotensin II but was inhibited reversibly by microbial PKC-inhibitors, K252a and staurosporine at concentrations (1.56-2.8 micrograms/kg/min) which did not block vasoconstriction by phenylephrine or 5-hydroxytryptamine. The EC50 for PDBu was identical in SHR and WKY. However, the maximal response to PDBu was significantly greater in SHR compared to WKY. Staurosporine lowered mean arterial pressure equally in SHR (20%) and WKY (17%) but reduced perfusion pressure in SHR (13%) to a slightly greater extent than in WKY (5%). Unlike the in vivo response, aortic rings removed from SHR were more sensitive to cumulative doses of PDBu than rings from WKY. It is concluded that PDBu-vasoconstriction in vivo is mediated largely through activation of PKC.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Comparative effects of tramadol on vascular reactivity in normotensive and spontaneously hypertensive rats.
Raimundo JM, Pontes LB, Antunes F, Sudo RT, Trachez MM, Zapata-Sudo G. Raimundo JM, et al. Clin Exp Pharmacol Physiol. 2008 Oct;35(10):1197-203. doi: 10.1111/j.1440-1681.2008.04979.x. Epub 2008 Jun 1. Clin Exp Pharmacol Physiol. 2008. PMID: 18518879 - Protein kinase C and vascular smooth muscle contractility: effects of inhibitors and down-regulation.
Merkel LA, Rivera LM, Colussi DJ, Perrone MH. Merkel LA, et al. J Pharmacol Exp Ther. 1991 Apr;257(1):134-40. J Pharmacol Exp Ther. 1991. PMID: 2019982
Cited by
- Vascular smooth muscle contraction in hypertension.
Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, Montezano AC. Touyz RM, et al. Cardiovasc Res. 2018 Mar 15;114(4):529-539. doi: 10.1093/cvr/cvy023. Cardiovasc Res. 2018. PMID: 29394331 Free PMC article. Review. - Prenatal testosterone exposure induces hypertension in adult females via androgen receptor-dependent protein kinase Cδ-mediated mechanism.
Blesson CS, Chinnathambi V, Hankins GD, Yallampalli C, Sathishkumar K. Blesson CS, et al. Hypertension. 2015 Mar;65(3):683-690. doi: 10.1161/HYPERTENSIONAHA.114.04521. Epub 2014 Dec 8. Hypertension. 2015. PMID: 25489059 Free PMC article. - Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular Disease.
Khalil RA. Khalil RA. Pharmaceuticals (Basel). 2013;6(3):407-39. doi: 10.3390/ph6030407. Pharmaceuticals (Basel). 2013. PMID: 23580870 Free PMC article. - Apurinic/apyrimidinic endonuclease 1 inhibits protein kinase C-mediated p66shc phosphorylation and vasoconstriction.
Lee SK, Chung JI, Park MS, Joo HK, Lee EJ, Cho EJ, Park JB, Ryoo S, Irani K, Jeon BH. Lee SK, et al. Cardiovasc Res. 2011 Aug 1;91(3):502-9. doi: 10.1093/cvr/cvr095. Epub 2011 Apr 4. Cardiovasc Res. 2011. PMID: 21467074 Free PMC article. - Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum.
Jin L, Teixeira CE, Webb RC, Leite R. Jin L, et al. Eur J Pharmacol. 2008 Aug 20;590(1-3):363-8. doi: 10.1016/j.ejphar.2008.06.001. Epub 2008 Jun 7. Eur J Pharmacol. 2008. PMID: 18614166 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical